Omission of breast surgery in exceptional responders after neoadjuvant chemotherapy—what are future possibilities?—a narrative review
Translational Breast Cancer Research · 2025-04 · 6 · 13-13
DOI: 10.21037/tbcr-24-65 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Breast Cancer Research, 2025-04. Verfasst von Frances Phang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.
- Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.
Zitieren
APA
Phang, F., & Weiss, A. (2025). Omission of breast surgery in exceptional responders after neoadjuvant chemotherapy—what are future possibilities?—a narrative review. Translational Breast Cancer Research, 6, 13-13. https://doi.org/10.21037/tbcr-24-65
Vancouver
Phang F, Weiss A. Omission of breast surgery in exceptional responders after neoadjuvant chemotherapy—what are future possibilities?—a narrative review. Translational Breast Cancer Research. 2025;6:13-13. doi:10.21037/tbcr-24-65
BibTeX
@article{Phang2025,
author = {Phang, Frances and Weiss, Anna},
title = {Omission of breast surgery in exceptional responders after neoadjuvant chemotherapy—what are future possibilities?—a narrative review},
journal = {Translational Breast Cancer Research},
year = {2025},
volume = {6},
pages = {13--13},
doi = {10.21037/tbcr-24-65}
}
EUVIMED